| COVID-19 |
1 |
1 |
| COVID-19 Vaccine |
0 |
0.81 |
| Immunization |
0 |
0.99 |
| Severe Acute Respiratory Syndrome |
0 |
0.5 |
| COVID-19 Delta Variant |
0 |
0.39 |
| Acute Respiratory Distress Syndrome |
0 |
0.31 |
| Rheumatic Disease |
0 |
0.98 |
| Vaccines |
0 |
0.19 |
| Biologic Therapy |
0 |
0.17 |
| Tumor Necrosis Factor-Alpha |
0 |
0.12 |
| Antineoplastic Drug |
0 |
0.1 |
| Blood |
0 |
0.1 |
| Cardiovascular disease |
0 |
0.1 |
| Concerns of Elderly |
0 |
0.1 |
| Geriatrics |
0 |
0.1 |
| Hospital |
0 |
0.1 |
| Monoclonal Antibody |
0 |
0.1 |
| Connective Tissue Disease |
0 |
0.07 |
| Hypertension |
0 |
0.07 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.07 |
| Cardiovascular Risk Management |
0 |
0.06 |
| Vasculitis |
0 |
0.06 |
| Arthritis |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.05 |
| Europe |
0 |
0.05 |
| Finger |
0 |
0.05 |
| Glucocorticoid |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Stress |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Rheumatoid Arthritis |
0 |
0.04 |
| Complementary and Alternative Medicine |
0 |
0.03 |
| Obesity |
0 |
0.03 |